New China Approvals Include Amgen, Sanofi, Hengrui Drugs, Innovent Biosimilar

 
• By Brian Yang

Several high-profile products including Dupixent gain approvals in China.

Beijing, China (ESB Professional/Shutterstock.com)
CHINA CONTINUES NEW APPROVALS RUSH POST-CORONAVIRUS • Source: Shutterstock

More from China

More from Asia